Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study
Background: Liposomal doxorubicin hypersensitivity significantly affects breast cancer patients, with widely varying incidence rates (9 % to 46 %). Despite its efficacy, this condition poses a critical barrier to treatment due to the need for precise patient management and the absence of effective p...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-01-01
|
| Serier: | Cancer Treatment and Research Communications |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2468294226000158 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
